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DNA amplification is essential to most nucleic acid testing strategies, but established techniques require sophisticated
equipment or complex experimental procedures, and their uptake outside specialised laboratories has been limited.
Our novel approach, recombinase polymerase amplification (RPA), couples isothermal recombinase-driven primer
targeting of template material with strand-displacement DNA synthesis. It achieves exponential amplification with no
need for pretreatment of sample DNA. Reactions are sensitive, specific, and rapid and operate at constant low
temperature. We have also developed a probe-based detection system. Key aspects of the combined RPA
amplification/detection process are illustrated by a test for the pathogen methicillin-resistant Staphylococcus aureus.
The technology proves to be sensitive to fewer than ten copies of genomic DNA. Furthermore, products can be
detected in a simple sandwich assay, thereby establishing an instrument-free DNA testing system. This unique
combination of properties is a significant advance in the development of portable and widely accessible nucleic acid–
based tests.
Citation: Piepenburg O, Williams CH, Stemple DL, Armes NA (2006) DNA detection using recombination proteins. PLoS Biol 4(7): e204. DOI: 10.1371/journal.pbio.0040204
Introduction
The ampliﬁcation of DNA is an essential step in most
nucleic acid–based testing strategies. Established ampliﬁca-
tion techniques rely on sophisticated instrumentation, such
as temperature-regulating equipment or complex sample-
handling procedures. While unproblematic for specialised
laboratories, these requirements have hampered the uptake
of nucleic acid analyses in point-of-use and ﬁeld settings. The
technology presented in this study, recombinase polymerase
ampliﬁcation (RPA), overcomes the technical difﬁculties
posed by current DNA ampliﬁcation methods. It does not
require thermal denaturation of template and operates at a
low and constant temperature. In combination with a novel
probe-based detection approach, RPA constitutes a signiﬁ-
cant advance in the development of portable and widely
accessible nucleic acid–based tests.
In RPA, the isothermal ampliﬁcation of speciﬁc DNA
fragments is achieved by the binding of opposing oligonu-
cleotide primers to template DNA and their extension by a
DNA polymerase (Figure 1A). Global melting of the template
is not required for the primers to be directed to their
complementary target sequences. Instead, RPA employs
recombinase-primer complexes to scan double-stranded
DNA and facilitate strand exchange at cognate sites [1–3].
The resulting structures are stabilised by single-stranded
DNA binding proteins interacting with the displaced tem-
plate strand, thus preventing the ejection of the primer by
branch migration [4]. Recombinase disassembly leaves the 39-
end of the oligonucleotide accessible to a strand displacing
DNA polymerase, in this case the large fragment of Bacillus
subtilis Pol I (Bsu, [5]), and primer extension ensues.
Exponential ampliﬁcation is accomplished by the cyclic
repetition of this process. The key to RPA is the establish-
ment of a dynamic reaction environment that balances the
formation and disassembly of recombinase-primer ﬁlaments
(Figure 1B). The recombinase we have employed, T4 uvsX,
binds cooperatively to oligonucleotides in the presence of
ATP. The resulting nucleoprotein complex actively hydrol-
yses ATP, and spontaneous recombinase disassembly in the
ADP-bound state can lead to its replacement by T4 gp32, a
single-stranded DNA binding protein necessary for the
reaction. We found that a unique combination of T4 uvsY,
a recombinase loading factor [6], and a particular crowding
agent (Carbowax20M) establishes favourable reaction con-
ditions that support RPA (see Protocol S1 and Figures S1 to
S3). The proteins used in our approach are central
components of in vivo processes required for cellular DNA
synthesis, recombination, and repair and have been the
subject of intensive research for a number of years [7]. In
addition to facilitating DNA ampliﬁcation in the RPA
context, the dynamic reaction environment described here
provides a system for the in vitro study of the recombination
machinery and will aid the development of laboratory
procedures that replace conventional hybridisation techni-
ques.
Results/Discussion
We applied the RPA process to a wide variety of targets in
complex DNA templates. The versatility and speciﬁcity of the
technology are exempliﬁed by the ampliﬁcation of three
genetic markers, apolipoprotein B (apoB), sex-determining
region Y (Sry), and porphobilinogen deaminase (PBDG), from
complex human genomic DNA (Figure 2A). While the
negative controls did not produce a signal, clean ampliﬁca-
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PLoS BIOLOGYtion products of the correct identity (Figure S4) were
generated in each template-containing sample.
The progression of RPA reactions can be monitored in real-
time by the inclusion of a sensitive nucleic acid dye (Figure
2B) [8]. Here, primers for a locus in the B. subtilis genome have
been used. The ampliﬁcation of DNA proved to be exponen-
tial over a wide range of template concentrations and results
were obtained in less than 30 min. The onset of ampliﬁcation
depends linearly on the logarithm of the starting number of
template copies. Reactions carried out in the absence of
template or at low template concentrations eventually
generated a nonspeciﬁc signal, an effect brought about by a
primer-dependent artefact (Figure 2B, water control).
To devise a highly sensitive RPA detection system that is
not affected by primer artefacts, we developed a probe-based
detection method (Figure 3A). The probe we use contains a
tetrahydrofuran abasic–site mimic (THF) [9], ﬂanked in close
proximity by nucleotides modiﬁed with a ﬂuorophore and a
quencher. The ﬂuorescence of the intact construct is low. A
block at the 39-end prevents the oligonucleotide from acting
as an ampliﬁcation primer. Pairing of the probe to
complementary DNA enables the recognition of the THF by
the double-strand–speciﬁc Escherichia coli endonuclease IV
(Nfo) [10]. The need for formation of a stable DNA duplex
acts as an additional speciﬁcity-proofreading step in the
context of our detection approach. Subsequent cutting of the
probe separates the ﬂuorophore/quencher complex and leads
to a measurable increase in ﬂuorescence. The cleavage
reaction generates a free 39 OH-end on the 59 remnant of
the incised probe. This oligomer can then be elongated by
Bsu polymerase, thus serving as an ampliﬁcation primer.
To demonstrate the performance of combined RPA and
probe/nuclease-based read-out, we designed primers and
probes for the detection of the common hospital pathogen
Figure 2. RPA Amplifies Specific Target Regions from Complex DNA
Templates in less than 30 Minutes
(A) Acrylamide gel electrophoresis of RPA products using primers for
three human markers (apoB, Sry, PBDG). Water ( ) or 1,000 copies of
genomic DNA (þ) served as template. Ten percent of each reaction is
loaded on the gel. The expected product sizes are 305, 371, and 353
base-pairs for apoB, Sry, and PBDG, respectively.
(B) Real-time RPA using primers for the B. subtilis SpoB locus.
Fluorescence upon intercalation of SybrGreenI into nascent product is
detected. B. subtilis DNA served as template in triplicate reactions at 10
5
(black), 10
4 (red), 10
3 (yellow), or 100 copies (green) or water (blue). The
onset of amplification depends linearly on the logarithm of the starting
template copy number [see inset; time in minutes (midpoint of growth
curve) versus log ftemplate concentration in copy number)].
DOI: 10.1371/journal.pbio.0040204.g002
Figure 1. Schematic of the RPA Process and the Recombinase/Primer
Filament Formation
(A) Recombinase/primer filaments scan template DNA for homologous
sequences (red/blue). Following strand exchange, the displaced strand is
bound by gp32 (green), primers are extended by Bsu polymerase (blue).
The net result of two opposing primer binding/extension events is the
generation of one complete copy of the amplicon in addition to the
original template. Repetition of the process results in exponential DNA
amplification.
(B) In the presence of ATP, uvsX (gray) binds cooperatively to
oligonucleotides (red, top). Upon ATP hydrolysis, the nucleoprotein
complex disassembles (left) and uvsX can be replaced by gp32 (green,
right). The presence of uvsY and Carbowax20M shifts the equilibrium in
favour of recombinase loading.
DOI: 10.1371/journal.pbio.0040204.g001
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DNA Detection Using Recombinasesmethicillin-resistant Staphylococcus aureus (MRSA; Figure 3B)
[11]. The sensitivity and reproducibility of RPA were explored
by the ampliﬁcation of the staphylococcal cassette chromo-
some mec (SCCmec) integration locus of the isoform MRSAIII
(Figure 4A, see Protocol S1 for sequences). The onset of
ampliﬁcation at identical starting template quantities of ten,
100, 1,000, or 10,000 copies was virtually simultaneous,
demonstrating the robustness of the technique. A plot of
the time of beginning ampliﬁcation against the logarithm of
starting copy number reveals a linear relationship (Figure
4B). At low template amounts (two copies), the ampliﬁcation
times are distributed over a wider period, with one reaction
failing to generate a signal at all, and the correlation between
onset of ampliﬁcation and template concentration breaks
down. However, product detection in samples with such low
template concentrations supports the notion that RPA can
essentially attain single template copy sensitivity.
The high sensitivity and speciﬁcity of RPA allow the design
of a multiplex approach in which different amplicons are
generated and detected in the same reaction. Three poly-
morphic alleles of the SCCmec integration region represent
the vast majority of known MRSA genotypes (MRSAI through
III; Figure 5A) [12]. While they share the genomic locus orfX,
they differ in the sequence of the SCCmec. The integrating
elements of MRSAI and II are homologous to each other
except for a 102–base-pair insertion/deletion, while the
MRSAIII SCCmec is highly divergent. A primer shared by all
alleles was designed for the common region (orfX), whereas
primers speciﬁc for MRSAI/II and MRSAIII target the
different SCCmec variants (sccI/II and III, respectively). To
ensure detection of all three isoforms, we designed two highly
homologous probes (to account for polymorphisms) for the
common region (SATamra1 and SATamra2). Fusing the
target sequences for the primers sccIII and orfX to an
unrelated DNA sequence created an internal control for the
reaction. To verify the activity of each sample, the ampliﬁ-
cation of this construct was monitored simultaneously with
that of the MRSA targets using another probe of appropriate
sequence and bearing a different ﬂuorophore/quencher pair
(BSFlc). We employed this combination of primers and
probes to detected ten genomic copies of the three MRSA
types (Figure 5B). By contrast, the closely related methicillin-
sensitive Staphylococcus aureus (MSSA; 10
4 copies) serving as a
negative control did not generate a signal, despite being
ampliﬁed by suitable primers (see Figure S5). The internal
control was concomitantly detected in all samples.
Figure 3. Schematic of the Probe-Based RPA Detection Method
(A) Signal generation by separation of a fluorophore and a quencher
depends on cutting of the probe by double-strand specific Nfo.
(B) Arrangement of primers and probes relative to the targets used in
Figures 4 and 5. See Protocol S1 for sequences of MRSA isoforms. A PCR
fragment that fused an unrelated sequence to the target sites sccIII and
orfX served as internal control.
DOI: 10.1371/journal.pbio.0040204.g003
Figure 4. RPA Enables Specific DNA Amplification from Few Template
Molecules
(A) Probe signal of RPA reactions using the primer set orfX/sccIII (see
Figure 3). MRSAIII DNA at 10
4 (black, reactions 1–3), 10
3 (red, 4–6), 100
(yellow, 7–9), ten (green, 10–12), or two (purple, 13–17) copies or water
(blue, 18–20) served as template.
(B) A plot of the onset time of amplification (defined as passing the 2.5
threshold) in reactions 1 to 12 in Figure 4A against the logarithm of the
template copy number reveals a linear relationship.
DOI: 10.1371/journal.pbio.0040204.g004
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DNA Detection Using RecombinasesThe combination of RPA and the described nuclease-
sensitive ﬂuorophore/quencher probes constitutes a DNA
ampliﬁcation/detection system that would require no other
equipment than a simple handheld ﬂuorometer, thus making
quantitative DNA testing potentially accessible in a non-
laboratory point-of-care environment. We devised an even
simpler detection approach by employing lateral-ﬂow dip-
stick technology. This system is often used as a simple
disposable diagnostic device. It employs pairs of speciﬁc
antibodies to immobilise and detect entities containing two
antigenic labels (Figure 6A). Reaction mixtures (see below)
are applied to a sample pad soaked in visible gold particles
that are coupled to an antibody recognising one antigen. The
complexes then travel in a buffer stream through the
membrane and an additional, immobilised antibody captures
the second antigen. If the antigens are conjoined in a DNA
duplex, a coloured line appears at a deﬁned location on the
strip. A second line of immobilised antibodies captures the
gold-conjugated antibody directly, whether conjoined to the
other antigen or not, and serves as a ﬂow control for the strip.
In a variation of our probe detection system, we produced
such dual antigen complexes by coupling biotin- and
carboxyﬂuorescein (FAM)-bearing oligonucleotides in RPA
amplicons (Figure 6B). The 59-biotinylated primer and its
opposing counterpart ensure the efﬁcient ampliﬁcation of a
target for probe binding. The probe, including a 59-FAM
label, an internal THF, and a 39-blocking group, is incised by
Nfo upon binding, creating a 39 OH substrate for elongation
by Bsu. The extension of the probe remnant stabilises its
interaction with the biotin-labeled opposing strand and
produces an amplicon that contains both antigens, biotin
and FAM. The THF/39 block prevents the production of
biotin/FAM-containing primer artefacts, as processing of
bona ﬁde duplexes by Nfo adds a critical proofreading step.
We used a multiplex approach similar to the one employed in
Figure 5 to detect ten copies of each of the three MRSA
isoforms and distinguish them from MSSA (Figure 6C). As
before, we designed two highly homologous probes (to
account for polymorphisms) for the common region (Lfs1
and Lfs2). RPA reactions were followed by the application of
the reaction mixtures to the sample pads of lateral-ﬂow
strips. Samples containing the MRSA template created biotin/
FAM-amplicons and generated visible signals on the anti-
biotin detection line. In contrast, the MSSA-containing
negative control failed to produce a conjoined complex and
gave rise to the ﬂow-control line only.
A number of research and clinical applications could
beneﬁt from employing RPA. Perhaps most obviously, the
technology offers a signiﬁcant breakthrough for the develop-
ment of nonlaboratory devices. When integrated with
handheld instruments or entirely equipment-free DNA
detection systems, RPA will enable an easy-to-use testing
system for a variety of pathogens as well as ﬁeld kits for other
applications.
Materials and Methods
Proteins and DNA. Coding sequences for uvsx, uvsy, gp32, Bsu, and
Nfo were ampliﬁed from genomic DNA (DSMZ, Braunschweig
Germany), fused to hexahistidine-tags (N-terminal for uvsY, Bsu,
and Nfo, C-terminal for uvsX and gp32), and cloned into suitable
expression vectors. Overexpression and puriﬁcation were done by
standard protocols using nickel-NTA resin (Qiagen, Valencia,
California, United States). Human genomic DNA was from Promega
(Madison, Wisconsin, United States), B. subtilis DNA was from ATCC
(American Type Culture Collection, Manassas, Virginia, United
States), and S. aureus DNAs were a gift from Jodi Lindsay (University
of London, London, England). S. aureus strains were EMRSA-3
(SCCmec type I; MRSAI), EMRSA-16 (MRSAII), EMRSA-1 (MRSAIII),
and wild-type MSSA.
RPA conditions. Reactions were performed at 37 8C for 60 min or
as indicated. Standard conditions were 50 mM Tris (pH 7.9), 100 mM
potassium acetate, 14 mM magnesium acetate, 2 mM DTT, 5%
Carbowax20M, 200 lM dNTPs, 3 mM ATP, 50 mM phosphocreatine,
100 ng/ll creatine kinase, and 30 ng/ll Bsu; in the multiplex
experiment, Carbowax20M was at 5.5%. Recombinase protein
concentrations were 900 ng/ll gp32, 120 ng/ll uxsX, and 30 ng/ll
uvsY. Primers used for ampliﬁcation of human targets were apoB4,
apoB300, sry3, sry4, pbdg5, pbdg6 (300 nM each), for B. subtilis, bs1
and bs2 were used (300 nM each) in the experiment in Figure 2B. For
MRSA ampliﬁcation, primers used were 500 nM sccIII, 100 nM orfX
(Figure 4A) or 265 nM sccI/II, 265 nM sccIII, 70 nM orfX (Figure 5) or
240 nM Bio-sccI/II, 240 nM Bio-sccIII, 120 nM orfX (Figure 6).
Reaction volumes were 20 ll, except for the experiment shown in
Figure 2A (40 ll).
Real-time monitoring. Real-time RPA was performed in a plate-
reader (Flx-800; BioTek, Winooski, Vermont, United States) in the
Figure 5. A Multiplex RPA Approach Enables Detection of Different
MRSA Alleles and an Internal Control in the Same Reaction
(A) MRSAI (green), MRSAII (dark blue), MRSAIII DNA (red) at ten copies, or
MSSA DNA at 10
4 copies (blue, negative control) or water (yellow,
turquoise, negative controls) served as a template (in triplicate for each
template condition). See Figure 3 for the arrangement of primers and
probes used.
(B) Detection of 50 copies of internal control DNA included in the
reactions in (A). Note that two of the negative control sets (blue, yellow)
included internal control template, whereas one set of reactions
(turquoise) contained water only and served as ‘‘double negative’’
control.
DOI: 10.1371/journal.pbio.0040204.g005
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DNA Detection Using Recombinasespresence of SybrGreenI (1:50,000; Molecular Probes, Eugene, Oregon,
United States) or ﬂuorophore/quencher probes (Eurogentec, San
Diego, California, United States). Three probes were used:
SATamra1 59-tgttaattgaacaagtgtacagagcatt(T)a(H)ga(q1)tatgcgtg-
gag-biotin-39
SATamra2 59-tgttaattgagcaagtgtatagagcatt(T)a(H)ga(q2)tatgcgtg-
gag-biotin-39
BSFlc59-catgattggatgaataagctgcagc(F)g(H)t(q3)aaaggaaactta-biotin-39
Here, (T) is dT-TAMRA, (F) is dT-ﬂuorescein, (H) is THF, (q1) is
dT-BHQ1, (q2) is dT-BHQ2, and (q3) is dT-DDQ1. Probes were used
at 60 nM SATamra1 (MRSAIII experiment) or at 45 nM SATamra1, 45
nM SATamra2, 60 nM BSFlc (multiplex experiment). Nfo was used at
200 ng/ll. Excitation/detection was at 485/525 nm (SybrGreenI, BSFlc)
or 530/575 nm (SATamra1/2). Measurements were taken every 30 or
45 s (multiplex experiment). Fluorescence probe data were normal-
ised (subtraction of water control average) and preampliﬁcation
Figure 6. RPA for MRSA Detection Can Be Combined with an Instrumentation-Free Read-out System
(A) Schematic of the principle of product generation and lateral-flow strip detection (see text for details). FAM label (green), biotin label (red), a-FAM-
gold (purple), a-biotin antibody (Y, detection line, filled arrowhead), species-specific a-[a-FAM-gold] antibody (T, control line, open arrowhead).
(B) Schematic of the lateral-flow probe design (top, here Lfs1) and its arrangement relative to amplification primers (bottom, here orfX and sccI/II). FAM
label (green), biotin label (red).
(C) Lateral-flow strips used for the detection of RPA products. Reactions contained (left to right) ten copies of MRSAIII, ten copies of MRSAII, ten copies
of MRSAI, or 10,000 copies of MSSA (negative control) as template. Positive signals are generated in the first three reactions (filled arrowhead). The
MSSA control reaction only produced a flow-control signal.
DOI: 10.1371/journal.pbio.0040204.g006
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DNA Detection Using Recombinasesbaseline adjusted. The logarithm of the read-out was plotted against
reaction time.
Lateral-ﬂow strip detection. For lateral-ﬂow strip experiments, two
probes were used at 75 nM each:
Lfs1 59-FAM-ccacatcaaatgatgcgggttgtgttaat(H)gaacaagtgtacagag-
ddC-39
Lfs2 59-FAM-ccacatcaaatgatgcgggttgtgttaat(H)gagcaagtgtatagag-
ddC-39
The 59-biotinylated forms of sccI/II and sccIII were utilised as
primers. For each reaction (20 ll), 1 ll was diluted with 5 llo f
running buffer (PBS/3% Tween) and applied directly to HybriDetect
strips (Milenia Biotec, Bad Nauheim, Germany) according to the
manufacturer’s instructions.
Supporting Information
Figure S1. Titrations of Reaction Components to Determine
Conditions that Support RPA
Polyacrylamide gel electrophoresis of RPA reactions using primers
for the human Sry locus. Reactions were performed at 37 8C for 120
min and contained the primers sry3 and sry4 at 300 nM, 50 mM Tris
(pH 8.4), 80 mM potassium acetate, 10 mM magnesium acetate, 2 mM
DTT, 3 mM ATP, 200 lM dNTPs, 20 mM phosphocreatine, 100 ng/ll
creatine kinase, 5% Carbowax20M, 600 ng/ll gp32, 200 ng/ll uvsX, 60
ng/ll uvsY, and 30 ng/ll Bsu, except when a given component was that
under investigation. Optimal quantities of (A) gp32, (B) uvsY, (C)
uvsX, (D) Carbowax20M, (E) ATP, and (F) Bsu for effective
ampliﬁcation of this particular target were determined. G) ADP-b-S
and (H) ATP-c-S inhibit the reactions. And 1,500 copies/ll of the
human Y-chromosomal DNA served as template in 30-ll reactions
(per sample the equivalent of 10-ll reaction volume was loaded on
the gel).
Found at DOI: 10.1371/journal.pbio.0040204.sg001 (159 KB PDF).
Figure S2. Investigation of Product Size Limits of RPA
Agarose gel electrophoresis of RPA reactions using primers for the
human apoB locus. Primer apoB4 was combined with opposing
primers capable of generating products of the indicated sizes.
Reactions were performed at 37 8C for 120 min, and conditions used
were 50 mM Tris (pH 8.4), 80 mM potassium acetate, 10 mM
magnesium acetate, 2 mM DTT, 3 mM ATP, 200 lM dNTPs, 20 mM
phosphocreatine,100 ng/llcreatinekinase,5% Carbowax20M,600 ng/
ll gp32,125 ng/ll uvsX, 25 ng/ll uvsY, and 30 ng/ll Bsu. And 450 copies
of human DNA were used as template in 30-ll reactions (per sample
the equivalent of 10-ll reaction volume was loaded on the gel). Note
that some hairpin-mediated product duplication occurred, convert-
ing some of the 300–base-pair amplicon to 23and 33unit length (*).
RPA failed to produce amplicons of 1,500 base-pairs or more.
Found at DOI: 10.1371/journal.pbio.0040204.sg002 (70 KB PDF).
Figure S3. Investigation of the Minimum Oligonucleotides Size
Necessary to Support RPA
Polyacrylamide gel electrophoresis of RPA reactions using primers
for the three independent loci in human genomic DNA (apoB,
D18S51, Sry). Primers were 25, 28, or greater than 31 bases, as
indicated. Reactions were performed at 37 8C for 120 min. Conditions
used were 50 mM Tris/Cl (pH 8.4), 80 mM potassium acetate, 10 mM
magnesium acetate, 2 mM DTT, 3 mM ATP, 200 lM dNTPs, 20 mM
phosphocreatine, 100 ng/ll creatine kinase, 5% Carbowax20M, 600
ng/ll gp32, 200 ng/ll uvsX, 60 ng/llu v s Y ,a n d3 0n g / llB s u
polymerase. And 3,000 copies of target served as template in 30-ll
reactions (per sample the equivalent of 10-ll reaction volume was
loaded on the gel). The ﬁnding that a primer length of greater than 28
bases is required to support RPA is in good agreement with reports
that investigated the ATP hydrolysis activity of uvsX-oligonucleotide
ﬁlaments at different oligonucleotide sizes [3].
Found at DOI: 10.1371/journal.pbio.0040204.sg003 (17 KB PDF).
Figure S4. Restriction Digest of RPA Products
Agarose gel electrophoresis of RPA reactions and their digestion
products. Primers for the human loci apoB (primers apoB4,
apoB300), Sry (primers sry3, sry4), and PBDG (primers pbdg5, pbdg6)
were used. Reactions were performed at 37 8C for 60 min, and
conditions used were 50 mM Tris (pH 7.9), 100 mM potassium acetate,
14 mM magnesium acetate, 2 mM DTT, 5% Carbowax20M, 200 lM
dNTPs, 3 mM ATP, 300 nM each primer, 50 mM phosphocreatine, 100
ng/ll creatine kinase, and 30 ng/ll Bsu. Recombinase protein
concentrations were 900 ng/ll gp32, 120 ng/ll uxsX, and 30 ng/ll
uvsY. And 1,000 copies of human genomic DNA served as template.
Reactions were performed in 40-ll volumes and puriﬁed using
GenElute Clean-Up kits (Sigma, St. Louis, Missouri, United States).
Ten percent of each reaction (equivalent to 4-ll RPA reaction) was
either loaded directly (uncut) or after digestion with XbaI (apoB and
Sry), HaeIII (apoB), or SmaI (PBDG) on a 2% agarose gel. The
restriction pattern conﬁrms the identity of the amplicons. Note that
the amplicon generated by apoB4 and apoB300 includes an SNP
covering the XbaI site. Since the template used is a combination of
genomic DNA from several donors (Promega), the apoB RPA product
consists of a mixture of fragments that either contain an XbaI site or
are refractory to XbaI digestion.
Found at DOI: 10.1371/journal.pbio.0040204.sg004 (92 KB PDF).
Figure S5. Probe Signal of RPA Reactions Using the Primer Set orfX/
MSSA and Probe SATamra2
(A) MSSA DNA at 10
4 (black, reactions 1–3), 10
3 (red, 4–6), 100
(yellow, 7–9), ten (green, 10–12), or two (purple, 13–17) copies or
MRSAI DNA at 10
4 copies (gray, reactions 18–20) or water (blue, 21–
23) served as template. Reaction conditions were 50 mM Tris (pH 7.9),
100 mM potassium acetate, 14 mM magnesium acetate, 2 mM DTT,
200 lM dNTPs, 3 mM ATP, 20 mM phosphocreatine, 100 ng/ll
creatine kinase, 5% Carbowax20M, 900 ng/ll gp32, 120 ng/ll uvsX, 30
ng/ll uvsY, and 30 ng/ll Bsu. Oligonucleotides were used at 500 nM
MSSA, 100 nM orfX, and 60 nM SATamra2. While the MSSA target is
ampliﬁed even at very low concentrations, the negative control
(MRSAI) does not generate a signal.
(B) A plot of the onset time of ampliﬁcation (deﬁned as passing the
2.5 threshold) in reactions 1 to 12 against the logarithm of the
template copy number reveals a linear relationship.
Found at DOI: 10.1371/journal.pbio.0040204.sg005 (53 KB PDF).
Protocol S1. Primer Sequences, Sequences of MRSA/MSSA Alleles,
RPA Conditions, Primer Requirements, and Control DNA
Found at DOI: 10.1371/journal.pbio.0040204.sd001 (32 KB DOC).
Accession Numbers
The National Center for Biotechnology Information (NCBI) (http://
www.ncbi.nlm.nih.gov) accession numbers used in this paper are Bsu
(NP_390787), T4 uvsX (NP_049656) T4 gp32 (NP_049854), T4 uvsY
(NP_049799), apoB (AY324608), Sry (NM_003140), PBDG
(AP003391), and Nfo (AP_002756) and SNP (SNP-ID rs693).
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